Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Trends in Bioinformatics
  Year: 2012 | Volume: 5 | Issue: 2 | Page No.: 25-46
DOI: 10.3923/tb.2012.25.46
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
In silico Modification of (1R, 2R, 3R, 5S)-(-)- Isopinocampheylamine as Inhibitors of M2 Proton Channel in Influenza A Virus Subtype H1N1, using the Molecular Docking Approach
U.S.F. Tambunan, R. Harganingtyas and A.A. Parikesit

Abstract:
In 2009, swine flu attacked various countries in the world. World Health Organization (WHO) set influenza A H1N1 virus disease as a global pandemic on June 11, 2009. At least, there are approximately 18,449 people worldwide who died from this virus attack. Then, on August 10, 2010, WHO officially announced that the swine flu pandemic in the world has ended and changed into post-pandemic phase. The post-pandemic phase is the most appropriate phase to find an antiviral that can overcome the infection with this virus. The existing antivirals, amantadine and rimantadine, are reported to have experienced resistance. Therefore, it is necessary to find a new antiviral to replace amantadine and rimantadine as the M2 channel protein inhibitor of influenza A H1N1 virus. Later, it was reported that compound (1R, 2R, 3R, 5S)-(-)- isopinocampheylamine has the ability to inhibit channel M2 protein of influenza A H1N1 virus. This research modified (1R, 2R, 3R, 5S)-(-)- isopinocampheylamine in silico to obtain better inhibitors. Three inhibitors docking with standard and 52 inhibitor modifications were performed against the M2 protein channel and drug scan for modification inhibitors was also conducted. Docking results had the three best binding affinity of modification inhibitors and its potency of inhibition is much better than the standard ligands. Based on drug analysis scan, the modified inhibitor has good pharmacological properties which are indicated by the value of drug-likeness, drug score, oral bioavailability and toxicity.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Modification of Kampmann A5 as Potential Fusion Inhibitor of Dengue Virus using Molecular Docking and Molecular Dynamics Approach
  •    Screening of Commercial Cyclic Peptides as Inhibitor Envelope Protein Dengue Virus (DENV) Through Molecular Docking and Molecular Dynamics
  •    Hail Community Acceptance of A/H1N1 Vaccine
  •    In silico Molecular Docking of Influenza Virus (PB2) Protein to Check the Drug Efficacy
  •    A Proposed Mathematical Model of Influenza A, H1N1 for Malaysia
  •    Molecular Docking Analysis of Phyto-Ligands with Multi Drug Resistant β-lactamases of Staphylococcus aureus
How to cite this article:

U.S.F. Tambunan, R. Harganingtyas and A.A. Parikesit, 2012. In silico Modification of (1R, 2R, 3R, 5S)-(-)- Isopinocampheylamine as Inhibitors of M2 Proton Channel in Influenza A Virus Subtype H1N1, using the Molecular Docking Approach. Trends in Bioinformatics, 5: 25-46.

DOI: 10.3923/tb.2012.25.46

URL: https://scialert.net/abstract/?doi=tb.2012.25.46

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 

       

       

Curve Bottom